The therapeutic effects of bee venom on some metabolic and antioxidant parameters associated with HFD-induced non-alcoholic fatty liver in rats

The present study was designed to investigate the therapeutic effects of bee venom (BV) on high-fat diet (HFD)-induced non-alcoholic fatty liver (NAFL) in rats at different levels. Histological manifestations, hepatic lipid content, liver function tests, glucose homeostasis, lipid abnormalities, adi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental and therapeutic medicine 2018-06, Vol.15 (6), p.5091-5099
Hauptverfasser: Hanafi, Mervat Y, Zaher, Eman L M, El-Adely, Soha E M, Sakr, Ahmed, Ghobashi, Ahmed H M, Hemly, Madiha H, Kazem, Amani H, Kamel, Maher A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5099
container_issue 6
container_start_page 5091
container_title Experimental and therapeutic medicine
container_volume 15
creator Hanafi, Mervat Y
Zaher, Eman L M
El-Adely, Soha E M
Sakr, Ahmed
Ghobashi, Ahmed H M
Hemly, Madiha H
Kazem, Amani H
Kamel, Maher A
description The present study was designed to investigate the therapeutic effects of bee venom (BV) on high-fat diet (HFD)-induced non-alcoholic fatty liver (NAFL) in rats at different levels. Histological manifestations, hepatic lipid content, liver function tests, glucose homeostasis, lipid abnormalities, adipocytokines, lipid peroxidation, disturbed glutathione and antioxidant enzymes systems and dysregulation of Nrf2 transcription factor were assessed. In the present study, the NAFL rats were subcutaneously treated with BV with different doses (0.01, 0.05, 0.1 mg/kg). The results indicated that BV treatment completely normalized the lipid profile values of NAFL rats. Fasting blood sugar, insulin level and homeostatic model assessment of insulin resistance significantly decreased. BV treated rats showed a significantly lower level of all liver enzymes and bilirubin. Moreover, BV treatment significantly increased the levels of active nuclear erythroid factor 2 like 2, glutathione (GSH) (total and reduced), GSH/glutathione disulphide ratio and activities of glutathione reductase, glutathione-S-transferase and glutathione peroxidase (total and Se-dependent). The level of tumor necrosis factor-α was reduced. Treatment showed correction of adiponectin level, and significant downregulation of hepatic triglycerides and cholesterol. At the histological level, BV improved the architecture of liver cells showing normal sinusoids. It may be concluded that BV may represent an interesting therapeutic alternative for the treatment of NAFL disease.
doi_str_mv 10.3892/etm.2018.6028
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5952098</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A552844490</galeid><sourcerecordid>A552844490</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-dc603e027f54b9e64edae735852c98d15fabba9f608a801980ab7f56f014f03b3</originalsourceid><addsrcrecordid>eNptkkFvFSEQxzdGY5vao1dD4sXLPoGFfXAxaaq1Jk281DOZZYc-ml14Avu0n8KvLM8-qzVCCGTmx38yk3_TvGR01SnN32KZV5wyteopV0-aY7bWvGWUyaeHN9WKHTWnOd_SumTPlJLPmyOuFZWyk8fNj-sNkrLBBFtcircEnUNbMomODIhkhyHOJAaS44xkxgJDnCoGYayn-Pjdj_UmW0hQs5gygZyj9VBwJN982ZDLi_etD-NiayDE0MJk4-aXiINS7sjkd5iIDyRByS-aZw6mjKeH-6T5cvHh-vyyvfr88dP52VVrheKlHW1PO6R87aQYNPYCR8B1J5XkVquRSQfDANr1VIGirLYLQ2V7R5lwtBu6k-bdve52GWYcLYaSYDLb5GdIdyaCN48zwW_MTdwZqSWvU60Cbw4CKX5dMBcz-2xxmiBgXLLhVPS1mO5FRV__g97GJYXaXqW0FB3jvfpD3cCExgcXa127FzVnUnIlhNC0Uqv_UHWPOHsbAzpf448-tPcfbIo5J3QPPTJq9iYy1URmbyKzN1HlX_09mAf6t2W6n9RIw-Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2095431268</pqid></control><display><type>article</type><title>The therapeutic effects of bee venom on some metabolic and antioxidant parameters associated with HFD-induced non-alcoholic fatty liver in rats</title><source>PubMed Central</source><creator>Hanafi, Mervat Y ; Zaher, Eman L M ; El-Adely, Soha E M ; Sakr, Ahmed ; Ghobashi, Ahmed H M ; Hemly, Madiha H ; Kazem, Amani H ; Kamel, Maher A</creator><creatorcontrib>Hanafi, Mervat Y ; Zaher, Eman L M ; El-Adely, Soha E M ; Sakr, Ahmed ; Ghobashi, Ahmed H M ; Hemly, Madiha H ; Kazem, Amani H ; Kamel, Maher A</creatorcontrib><description>The present study was designed to investigate the therapeutic effects of bee venom (BV) on high-fat diet (HFD)-induced non-alcoholic fatty liver (NAFL) in rats at different levels. Histological manifestations, hepatic lipid content, liver function tests, glucose homeostasis, lipid abnormalities, adipocytokines, lipid peroxidation, disturbed glutathione and antioxidant enzymes systems and dysregulation of Nrf2 transcription factor were assessed. In the present study, the NAFL rats were subcutaneously treated with BV with different doses (0.01, 0.05, 0.1 mg/kg). The results indicated that BV treatment completely normalized the lipid profile values of NAFL rats. Fasting blood sugar, insulin level and homeostatic model assessment of insulin resistance significantly decreased. BV treated rats showed a significantly lower level of all liver enzymes and bilirubin. Moreover, BV treatment significantly increased the levels of active nuclear erythroid factor 2 like 2, glutathione (GSH) (total and reduced), GSH/glutathione disulphide ratio and activities of glutathione reductase, glutathione-S-transferase and glutathione peroxidase (total and Se-dependent). The level of tumor necrosis factor-α was reduced. Treatment showed correction of adiponectin level, and significant downregulation of hepatic triglycerides and cholesterol. At the histological level, BV improved the architecture of liver cells showing normal sinusoids. It may be concluded that BV may represent an interesting therapeutic alternative for the treatment of NAFL disease.</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2018.6028</identifier><identifier>PMID: 29805535</identifier><language>eng</language><publisher>Greece: Spandidos Publications</publisher><subject>Antioxidants ; Care and treatment ; Cholesterol ; Development and progression ; Fasting ; Fatty liver ; Health aspects ; High fat diet ; Homeostasis ; Insulin resistance ; Laboratory animals ; Lipid peroxidation ; Lipids ; Liver ; Medical research ; Metabolic disorders ; Metabolism ; Methods ; Oxidative stress ; Pathogenesis ; Patient outcomes ; Rodents ; Tumor necrosis factor-TNF ; Variance analysis ; Venom immunotherapy</subject><ispartof>Experimental and therapeutic medicine, 2018-06, Vol.15 (6), p.5091-5099</ispartof><rights>COPYRIGHT 2018 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2018</rights><rights>Copyright © 2018, Spandidos Publications 2018</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-dc603e027f54b9e64edae735852c98d15fabba9f608a801980ab7f56f014f03b3</citedby><cites>FETCH-LOGICAL-c482t-dc603e027f54b9e64edae735852c98d15fabba9f608a801980ab7f56f014f03b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952098/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952098/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29805535$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hanafi, Mervat Y</creatorcontrib><creatorcontrib>Zaher, Eman L M</creatorcontrib><creatorcontrib>El-Adely, Soha E M</creatorcontrib><creatorcontrib>Sakr, Ahmed</creatorcontrib><creatorcontrib>Ghobashi, Ahmed H M</creatorcontrib><creatorcontrib>Hemly, Madiha H</creatorcontrib><creatorcontrib>Kazem, Amani H</creatorcontrib><creatorcontrib>Kamel, Maher A</creatorcontrib><title>The therapeutic effects of bee venom on some metabolic and antioxidant parameters associated with HFD-induced non-alcoholic fatty liver in rats</title><title>Experimental and therapeutic medicine</title><addtitle>Exp Ther Med</addtitle><description>The present study was designed to investigate the therapeutic effects of bee venom (BV) on high-fat diet (HFD)-induced non-alcoholic fatty liver (NAFL) in rats at different levels. Histological manifestations, hepatic lipid content, liver function tests, glucose homeostasis, lipid abnormalities, adipocytokines, lipid peroxidation, disturbed glutathione and antioxidant enzymes systems and dysregulation of Nrf2 transcription factor were assessed. In the present study, the NAFL rats were subcutaneously treated with BV with different doses (0.01, 0.05, 0.1 mg/kg). The results indicated that BV treatment completely normalized the lipid profile values of NAFL rats. Fasting blood sugar, insulin level and homeostatic model assessment of insulin resistance significantly decreased. BV treated rats showed a significantly lower level of all liver enzymes and bilirubin. Moreover, BV treatment significantly increased the levels of active nuclear erythroid factor 2 like 2, glutathione (GSH) (total and reduced), GSH/glutathione disulphide ratio and activities of glutathione reductase, glutathione-S-transferase and glutathione peroxidase (total and Se-dependent). The level of tumor necrosis factor-α was reduced. Treatment showed correction of adiponectin level, and significant downregulation of hepatic triglycerides and cholesterol. At the histological level, BV improved the architecture of liver cells showing normal sinusoids. It may be concluded that BV may represent an interesting therapeutic alternative for the treatment of NAFL disease.</description><subject>Antioxidants</subject><subject>Care and treatment</subject><subject>Cholesterol</subject><subject>Development and progression</subject><subject>Fasting</subject><subject>Fatty liver</subject><subject>Health aspects</subject><subject>High fat diet</subject><subject>Homeostasis</subject><subject>Insulin resistance</subject><subject>Laboratory animals</subject><subject>Lipid peroxidation</subject><subject>Lipids</subject><subject>Liver</subject><subject>Medical research</subject><subject>Metabolic disorders</subject><subject>Metabolism</subject><subject>Methods</subject><subject>Oxidative stress</subject><subject>Pathogenesis</subject><subject>Patient outcomes</subject><subject>Rodents</subject><subject>Tumor necrosis factor-TNF</subject><subject>Variance analysis</subject><subject>Venom immunotherapy</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptkkFvFSEQxzdGY5vao1dD4sXLPoGFfXAxaaq1Jk281DOZZYc-ml14Avu0n8KvLM8-qzVCCGTmx38yk3_TvGR01SnN32KZV5wyteopV0-aY7bWvGWUyaeHN9WKHTWnOd_SumTPlJLPmyOuFZWyk8fNj-sNkrLBBFtcircEnUNbMomODIhkhyHOJAaS44xkxgJDnCoGYayn-Pjdj_UmW0hQs5gygZyj9VBwJN982ZDLi_etD-NiayDE0MJk4-aXiINS7sjkd5iIDyRByS-aZw6mjKeH-6T5cvHh-vyyvfr88dP52VVrheKlHW1PO6R87aQYNPYCR8B1J5XkVquRSQfDANr1VIGirLYLQ2V7R5lwtBu6k-bdve52GWYcLYaSYDLb5GdIdyaCN48zwW_MTdwZqSWvU60Cbw4CKX5dMBcz-2xxmiBgXLLhVPS1mO5FRV__g97GJYXaXqW0FB3jvfpD3cCExgcXa127FzVnUnIlhNC0Uqv_UHWPOHsbAzpf448-tPcfbIo5J3QPPTJq9iYy1URmbyKzN1HlX_09mAf6t2W6n9RIw-Y</recordid><startdate>20180601</startdate><enddate>20180601</enddate><creator>Hanafi, Mervat Y</creator><creator>Zaher, Eman L M</creator><creator>El-Adely, Soha E M</creator><creator>Sakr, Ahmed</creator><creator>Ghobashi, Ahmed H M</creator><creator>Hemly, Madiha H</creator><creator>Kazem, Amani H</creator><creator>Kamel, Maher A</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180601</creationdate><title>The therapeutic effects of bee venom on some metabolic and antioxidant parameters associated with HFD-induced non-alcoholic fatty liver in rats</title><author>Hanafi, Mervat Y ; Zaher, Eman L M ; El-Adely, Soha E M ; Sakr, Ahmed ; Ghobashi, Ahmed H M ; Hemly, Madiha H ; Kazem, Amani H ; Kamel, Maher A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-dc603e027f54b9e64edae735852c98d15fabba9f608a801980ab7f56f014f03b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antioxidants</topic><topic>Care and treatment</topic><topic>Cholesterol</topic><topic>Development and progression</topic><topic>Fasting</topic><topic>Fatty liver</topic><topic>Health aspects</topic><topic>High fat diet</topic><topic>Homeostasis</topic><topic>Insulin resistance</topic><topic>Laboratory animals</topic><topic>Lipid peroxidation</topic><topic>Lipids</topic><topic>Liver</topic><topic>Medical research</topic><topic>Metabolic disorders</topic><topic>Metabolism</topic><topic>Methods</topic><topic>Oxidative stress</topic><topic>Pathogenesis</topic><topic>Patient outcomes</topic><topic>Rodents</topic><topic>Tumor necrosis factor-TNF</topic><topic>Variance analysis</topic><topic>Venom immunotherapy</topic><toplevel>online_resources</toplevel><creatorcontrib>Hanafi, Mervat Y</creatorcontrib><creatorcontrib>Zaher, Eman L M</creatorcontrib><creatorcontrib>El-Adely, Soha E M</creatorcontrib><creatorcontrib>Sakr, Ahmed</creatorcontrib><creatorcontrib>Ghobashi, Ahmed H M</creatorcontrib><creatorcontrib>Hemly, Madiha H</creatorcontrib><creatorcontrib>Kazem, Amani H</creatorcontrib><creatorcontrib>Kamel, Maher A</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hanafi, Mervat Y</au><au>Zaher, Eman L M</au><au>El-Adely, Soha E M</au><au>Sakr, Ahmed</au><au>Ghobashi, Ahmed H M</au><au>Hemly, Madiha H</au><au>Kazem, Amani H</au><au>Kamel, Maher A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The therapeutic effects of bee venom on some metabolic and antioxidant parameters associated with HFD-induced non-alcoholic fatty liver in rats</atitle><jtitle>Experimental and therapeutic medicine</jtitle><addtitle>Exp Ther Med</addtitle><date>2018-06-01</date><risdate>2018</risdate><volume>15</volume><issue>6</issue><spage>5091</spage><epage>5099</epage><pages>5091-5099</pages><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract>The present study was designed to investigate the therapeutic effects of bee venom (BV) on high-fat diet (HFD)-induced non-alcoholic fatty liver (NAFL) in rats at different levels. Histological manifestations, hepatic lipid content, liver function tests, glucose homeostasis, lipid abnormalities, adipocytokines, lipid peroxidation, disturbed glutathione and antioxidant enzymes systems and dysregulation of Nrf2 transcription factor were assessed. In the present study, the NAFL rats were subcutaneously treated with BV with different doses (0.01, 0.05, 0.1 mg/kg). The results indicated that BV treatment completely normalized the lipid profile values of NAFL rats. Fasting blood sugar, insulin level and homeostatic model assessment of insulin resistance significantly decreased. BV treated rats showed a significantly lower level of all liver enzymes and bilirubin. Moreover, BV treatment significantly increased the levels of active nuclear erythroid factor 2 like 2, glutathione (GSH) (total and reduced), GSH/glutathione disulphide ratio and activities of glutathione reductase, glutathione-S-transferase and glutathione peroxidase (total and Se-dependent). The level of tumor necrosis factor-α was reduced. Treatment showed correction of adiponectin level, and significant downregulation of hepatic triglycerides and cholesterol. At the histological level, BV improved the architecture of liver cells showing normal sinusoids. It may be concluded that BV may represent an interesting therapeutic alternative for the treatment of NAFL disease.</abstract><cop>Greece</cop><pub>Spandidos Publications</pub><pmid>29805535</pmid><doi>10.3892/etm.2018.6028</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1792-0981
ispartof Experimental and therapeutic medicine, 2018-06, Vol.15 (6), p.5091-5099
issn 1792-0981
1792-1015
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5952098
source PubMed Central
subjects Antioxidants
Care and treatment
Cholesterol
Development and progression
Fasting
Fatty liver
Health aspects
High fat diet
Homeostasis
Insulin resistance
Laboratory animals
Lipid peroxidation
Lipids
Liver
Medical research
Metabolic disorders
Metabolism
Methods
Oxidative stress
Pathogenesis
Patient outcomes
Rodents
Tumor necrosis factor-TNF
Variance analysis
Venom immunotherapy
title The therapeutic effects of bee venom on some metabolic and antioxidant parameters associated with HFD-induced non-alcoholic fatty liver in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T22%3A33%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20therapeutic%20effects%20of%20bee%20venom%20on%20some%20metabolic%20and%20antioxidant%20parameters%20associated%20with%20HFD-induced%20non-alcoholic%20fatty%20liver%20in%20rats&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Hanafi,%20Mervat%20Y&rft.date=2018-06-01&rft.volume=15&rft.issue=6&rft.spage=5091&rft.epage=5099&rft.pages=5091-5099&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2018.6028&rft_dat=%3Cgale_pubme%3EA552844490%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2095431268&rft_id=info:pmid/29805535&rft_galeid=A552844490&rfr_iscdi=true